

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.78786604 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.42356529 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.29709828 |
| 4 | muscle filament sliding (GO:0030049) | 5.14756707 |
| 5 | actin-myosin filament sliding (GO:0033275) | 5.14756707 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.86754370 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.76939835 |
| 8 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.74566105 |
| 9 | skeletal muscle contraction (GO:0003009) | 4.68820126 |
| 10 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.63298162 |
| 11 | vocalization behavior (GO:0071625) | 4.61548355 |
| 12 | neuronal action potential propagation (GO:0019227) | 4.49017208 |
| 13 | regulation of synapse structural plasticity (GO:0051823) | 4.47699505 |
| 14 | glutamate secretion (GO:0014047) | 4.47557707 |
| 15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.45549877 |
| 16 | synaptic vesicle exocytosis (GO:0016079) | 4.41127599 |
| 17 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.33749748 |
| 18 | cell communication by electrical coupling (GO:0010644) | 4.32376163 |
| 19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.31770481 |
| 20 | sodium ion export (GO:0071436) | 4.31270046 |
| 21 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.13937316 |
| 22 | cellular potassium ion homeostasis (GO:0030007) | 4.11846602 |
| 23 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.10691777 |
| 24 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.08284199 |
| 25 | actin-mediated cell contraction (GO:0070252) | 4.05393819 |
| 26 | cerebellar granule cell differentiation (GO:0021707) | 4.03747218 |
| 27 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.01654808 |
| 28 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.00216889 |
| 29 | regulation of synaptic vesicle transport (GO:1902803) | 4.00135328 |
| 30 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.96219210 |
| 31 | neurotransmitter secretion (GO:0007269) | 3.95176573 |
| 32 | plasma membrane repair (GO:0001778) | 3.92064104 |
| 33 | creatine metabolic process (GO:0006600) | 3.87530684 |
| 34 | activation of protein kinase A activity (GO:0034199) | 3.83457657 |
| 35 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.83148327 |
| 36 | potassium ion import (GO:0010107) | 3.82202628 |
| 37 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.81679207 |
| 38 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.81013340 |
| 39 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.77493802 |
| 40 | cell communication involved in cardiac conduction (GO:0086065) | 3.76716431 |
| 41 | NADH metabolic process (GO:0006734) | 3.75368843 |
| 42 | exploration behavior (GO:0035640) | 3.75067315 |
| 43 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.74998156 |
| 44 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.74709390 |
| 45 | layer formation in cerebral cortex (GO:0021819) | 3.72917328 |
| 46 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.72832159 |
| 47 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.68183337 |
| 48 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.65157771 |
| 49 | regulation of membrane repolarization (GO:0060306) | 3.64814579 |
| 50 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.63195119 |
| 51 | gamma-aminobutyric acid transport (GO:0015812) | 3.58736743 |
| 52 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.54594358 |
| 53 | protein localization to synapse (GO:0035418) | 3.54371208 |
| 54 | membrane depolarization during action potential (GO:0086010) | 3.49717969 |
| 55 | regulation of relaxation of muscle (GO:1901077) | 3.48595915 |
| 56 | regulation of cell communication by electrical coupling (GO:0010649) | 3.47900193 |
| 57 | dendritic spine morphogenesis (GO:0060997) | 3.47076184 |
| 58 | cardiac muscle contraction (GO:0060048) | 3.46271732 |
| 59 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.41875925 |
| 60 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.41875925 |
| 61 | long-term memory (GO:0007616) | 3.40937873 |
| 62 | response to parathyroid hormone (GO:0071107) | 3.40871138 |
| 63 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.39694795 |
| 64 | glycine transport (GO:0015816) | 3.37584237 |
| 65 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.37224553 |
| 66 | regulation of synapse maturation (GO:0090128) | 3.34757767 |
| 67 | proline transport (GO:0015824) | 3.34284053 |
| 68 | neuromuscular process controlling posture (GO:0050884) | 3.33373164 |
| 69 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.29814710 |
| 70 | synaptic transmission, glutamatergic (GO:0035249) | 3.29646808 |
| 71 | neuromuscular process controlling balance (GO:0050885) | 3.29097899 |
| 72 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.24321955 |
| 73 | cardiac myofibril assembly (GO:0055003) | 3.19712338 |
| 74 | skeletal muscle adaptation (GO:0043501) | 3.19039476 |
| 75 | sarcomere organization (GO:0045214) | 3.18551466 |
| 76 | glutamate receptor signaling pathway (GO:0007215) | 3.17685693 |
| 77 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.17061745 |
| 78 | actomyosin structure organization (GO:0031032) | 3.16161302 |
| 79 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.15551012 |
| 80 | actin filament-based movement (GO:0030048) | 3.14105080 |
| 81 | negative regulation of cell size (GO:0045792) | 3.14048417 |
| 82 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.13955643 |
| 83 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.12142818 |
| 84 | neurotransmitter transport (GO:0006836) | 3.11458078 |
| 85 | positive regulation of membrane potential (GO:0045838) | 3.09038279 |
| 86 | neuron-neuron synaptic transmission (GO:0007270) | 3.07238130 |
| 87 | cardiac muscle hypertrophy (GO:0003300) | 3.06339995 |
| 88 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.06130902 |
| 89 | detection of calcium ion (GO:0005513) | 3.04699847 |
| 90 | potassium ion homeostasis (GO:0055075) | 3.02883590 |
| 91 | regulation of ARF protein signal transduction (GO:0032012) | 3.01964692 |
| 92 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.01614077 |
| 93 | membrane repolarization (GO:0086009) | 2.99134376 |
| 94 | cell-substrate adherens junction assembly (GO:0007045) | 2.96702722 |
| 95 | focal adhesion assembly (GO:0048041) | 2.96702722 |
| 96 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.96549414 |
| 97 | regulation of postsynaptic membrane potential (GO:0060078) | 2.96495467 |
| 98 | regulation of actin filament-based movement (GO:1903115) | 2.96416484 |
| 99 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.95161816 |
| 100 | positive regulation of potassium ion transport (GO:0043268) | 2.94483917 |
| 101 | regulation of neurotransmitter levels (GO:0001505) | 2.92686561 |
| 102 | muscle contraction (GO:0006936) | 2.91667202 |
| 103 | regulation of synaptic plasticity (GO:0048167) | 2.91306412 |
| 104 | myofibril assembly (GO:0030239) | 2.91207696 |
| 105 | neuronal ion channel clustering (GO:0045161) | 2.90908705 |
| 106 | cerebellar Purkinje cell layer development (GO:0021680) | 2.90795172 |
| 107 | cardiac conduction (GO:0061337) | 2.90504202 |
| 108 | gluconeogenesis (GO:0006094) | 2.88476897 |
| 109 | striated muscle hypertrophy (GO:0014897) | 2.87956671 |
| 110 | regulation of cation channel activity (GO:2001257) | 2.87618804 |
| 111 | neuromuscular synaptic transmission (GO:0007274) | 2.87468756 |
| 112 | membrane depolarization (GO:0051899) | 2.87260468 |
| 113 | neuron cell-cell adhesion (GO:0007158) | 2.87041583 |
| 114 | cellular sodium ion homeostasis (GO:0006883) | 2.86863989 |
| 115 | striated muscle contraction (GO:0006941) | 2.86852707 |
| 116 | regulation of neurotransmitter secretion (GO:0046928) | 2.86550462 |
| 117 | regulation of transmembrane transporter activity (GO:0022898) | 2.85788829 |
| 118 | positive regulation of sodium ion transport (GO:0010765) | 2.85708037 |
| 119 | positive regulation of synapse maturation (GO:0090129) | 2.84983427 |
| 120 | striated muscle adaptation (GO:0014888) | 2.84047390 |
| 121 | regulation of skeletal muscle contraction (GO:0014819) | 2.82946423 |
| 122 | prepulse inhibition (GO:0060134) | 2.82814890 |
| 123 | auditory behavior (GO:0031223) | 2.82756112 |
| 124 | cell migration in hindbrain (GO:0021535) | 2.82070959 |
| 125 | vesicle transport along microtubule (GO:0047496) | 2.81759341 |
| 126 | adherens junction assembly (GO:0034333) | 2.79349963 |
| 127 | synaptic vesicle endocytosis (GO:0048488) | 2.76054819 |
| 128 | regulation of the force of heart contraction (GO:0002026) | 2.75878417 |
| 129 | skeletal muscle fiber development (GO:0048741) | 2.75687203 |
| 130 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.73573566 |
| 131 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.71476854 |
| 132 | muscle hypertrophy in response to stress (GO:0003299) | 2.69159793 |
| 133 | cardiac muscle adaptation (GO:0014887) | 2.69159793 |
| 134 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.69159793 |
| 135 | striated muscle atrophy (GO:0014891) | 2.67061834 |
| 136 | hexose biosynthetic process (GO:0019319) | 2.65345521 |
| 137 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.64302252 |
| 138 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.58056090 |
| 139 | muscle system process (GO:0003012) | 2.57670257 |
| 140 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.57352401 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.65405768 |
| 2 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.91015688 |
| 3 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.82510595 |
| 4 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.82015782 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.80616374 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.69619711 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.66580852 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.66580852 |
| 9 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.50768096 |
| 10 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.48664465 |
| 11 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.48344172 |
| 12 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.45988457 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.42445980 |
| 14 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.40423527 |
| 15 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.34471865 |
| 16 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 2.34314217 |
| 17 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.29284890 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.24165436 |
| 19 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.23077847 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.20074830 |
| 21 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.18760810 |
| 22 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.16659360 |
| 23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.14344160 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.12335306 |
| 25 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.12141623 |
| 26 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.06401630 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.02553506 |
| 28 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.90029698 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.88827618 |
| 30 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.83557041 |
| 31 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.79819112 |
| 32 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.69998407 |
| 33 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.68647151 |
| 34 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.64865434 |
| 35 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.64412270 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.62599285 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.60827325 |
| 38 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.59825678 |
| 39 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.59565926 |
| 40 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.58329909 |
| 41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57676233 |
| 42 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.56184264 |
| 43 | KDM2B_26808549_Chip-Seq_K562_Human | 1.55550039 |
| 44 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.53464780 |
| 45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.52790852 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52734585 |
| 47 | * P68_20966046_ChIP-Seq_HELA_Human | 1.52631882 |
| 48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.50434337 |
| 49 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.47411465 |
| 50 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.46953742 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46376636 |
| 52 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.45891055 |
| 53 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.44779675 |
| 54 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.43129210 |
| 55 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39304053 |
| 56 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.36493132 |
| 57 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.32360604 |
| 58 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.31714431 |
| 59 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.31132444 |
| 60 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.30577380 |
| 61 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29203599 |
| 62 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.28577264 |
| 63 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.28011883 |
| 64 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.25822388 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25265855 |
| 66 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.24878439 |
| 67 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24630512 |
| 68 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.23917575 |
| 69 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.23842599 |
| 70 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23454133 |
| 71 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22878699 |
| 72 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.20786262 |
| 73 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.20440163 |
| 74 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.19776037 |
| 75 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18268868 |
| 76 | * AR_19668381_ChIP-Seq_PC3_Human | 1.17804617 |
| 77 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.17663831 |
| 78 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.16974640 |
| 79 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.16924105 |
| 80 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15889927 |
| 81 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.15325480 |
| 82 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.15161228 |
| 83 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13991114 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10226301 |
| 85 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.08001334 |
| 86 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.06954662 |
| 87 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06200505 |
| 88 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.06039587 |
| 89 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.04153667 |
| 90 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03908124 |
| 91 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.02622620 |
| 92 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02489999 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.02102241 |
| 94 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.01492652 |
| 95 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01319255 |
| 96 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.00983079 |
| 97 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.00670628 |
| 98 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.00071396 |
| 99 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99987911 |
| 100 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.99482406 |
| 101 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.99446874 |
| 102 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99212776 |
| 103 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98942098 |
| 104 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.98850941 |
| 105 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.98377877 |
| 106 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.98367936 |
| 107 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97522636 |
| 108 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97522636 |
| 109 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.97262705 |
| 110 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97058845 |
| 111 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96985595 |
| 112 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96755809 |
| 113 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95601864 |
| 114 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.95137490 |
| 115 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.94451776 |
| 116 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.94365429 |
| 117 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.92270914 |
| 118 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.92027065 |
| 119 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.91763478 |
| 120 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.91212337 |
| 121 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91067802 |
| 122 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.91029226 |
| 123 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90781304 |
| 124 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90395766 |
| 125 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.90048258 |
| 126 | STAT3_23295773_ChIP-Seq_U87_Human | 0.89069415 |
| 127 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.88984752 |
| 128 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88883070 |
| 129 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.88621086 |
| 130 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.87770813 |
| 131 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.87598005 |
| 132 | AR_25329375_ChIP-Seq_VCAP_Human | 0.86522844 |
| 133 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86472709 |
| 134 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.86127983 |
| 135 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85971313 |
| 136 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.85899085 |
| 137 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.85140795 |
| 138 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.84825452 |
| 139 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.83979636 |
| 140 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.83691395 |
| 141 | RXR_22108803_ChIP-Seq_LS180_Human | 0.82414819 |
| 142 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.81599231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.88631739 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 3.51960754 |
| 3 | MP0000751_myopathy | 3.49453510 |
| 4 | * MP0003635_abnormal_synaptic_transmissio | 3.47587906 |
| 5 | MP0003880_abnormal_central_pattern | 3.38980013 |
| 6 | MP0003646_muscle_fatigue | 3.38144593 |
| 7 | MP0004270_analgesia | 3.19091435 |
| 8 | MP0009745_abnormal_behavioral_response | 2.78599366 |
| 9 | MP0002822_catalepsy | 2.73949630 |
| 10 | MP0009046_muscle_twitch | 2.71213896 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.64417973 |
| 12 | MP0002064_seizures | 2.62309764 |
| 13 | MP0004145_abnormal_muscle_electrophysio | 2.57858748 |
| 14 | MP0004215_abnormal_myocardial_fiber | 2.57097316 |
| 15 | MP0005451_abnormal_body_composition | 2.42301052 |
| 16 | MP0004084_abnormal_cardiac_muscle | 2.41268841 |
| 17 | MP0004036_abnormal_muscle_relaxation | 2.27814621 |
| 18 | MP0001968_abnormal_touch/_nociception | 2.27571549 |
| 19 | MP0005423_abnormal_somatic_nervous | 2.24979783 |
| 20 | MP0002272_abnormal_nervous_system | 2.24391153 |
| 21 | MP0003123_paternal_imprinting | 2.23277656 |
| 22 | MP0000749_muscle_degeneration | 2.19960636 |
| 23 | MP0002734_abnormal_mechanical_nocicepti | 2.12021704 |
| 24 | MP0008569_lethality_at_weaning | 2.10278962 |
| 25 | MP0002572_abnormal_emotion/affect_behav | 2.08767086 |
| 26 | MP0001486_abnormal_startle_reflex | 1.99483586 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 1.94141789 |
| 28 | MP0002909_abnormal_adrenal_gland | 1.93648437 |
| 29 | MP0003137_abnormal_impulse_conducting | 1.81974818 |
| 30 | MP0004858_abnormal_nervous_system | 1.79501076 |
| 31 | MP0004130_abnormal_muscle_cell | 1.75250354 |
| 32 | MP0009780_abnormal_chondrocyte_physiolo | 1.74967050 |
| 33 | MP0001501_abnormal_sleep_pattern | 1.73225525 |
| 34 | MP0010234_abnormal_vibrissa_follicle | 1.70862398 |
| 35 | MP0000747_muscle_weakness | 1.69320456 |
| 36 | MP0005330_cardiomyopathy | 1.68456687 |
| 37 | MP0003329_amyloid_beta_deposits | 1.68402130 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.68244495 |
| 39 | MP0002735_abnormal_chemical_nociception | 1.67681838 |
| 40 | MP0004087_abnormal_muscle_fiber | 1.66679782 |
| 41 | MP0002736_abnormal_nociception_after | 1.63340414 |
| 42 | MP0005620_abnormal_muscle_contractility | 1.61441280 |
| 43 | MP0004484_altered_response_of | 1.60473197 |
| 44 | MP0002067_abnormal_sensory_capabilities | 1.57896143 |
| 45 | MP0001970_abnormal_pain_threshold | 1.57433758 |
| 46 | MP0002733_abnormal_thermal_nociception | 1.54730331 |
| 47 | MP0004085_abnormal_heartbeat | 1.52331390 |
| 48 | MP0002972_abnormal_cardiac_muscle | 1.51868636 |
| 49 | MP0002106_abnormal_muscle_physiology | 1.49362812 |
| 50 | MP0004924_abnormal_behavior | 1.49145681 |
| 51 | MP0005386_behavior/neurological_phenoty | 1.49145681 |
| 52 | MP0004811_abnormal_neuron_physiology | 1.47888247 |
| 53 | MP0004233_abnormal_muscle_weight | 1.46709993 |
| 54 | MP0002269_muscular_atrophy | 1.41599888 |
| 55 | MP0001348_abnormal_lacrimal_gland | 1.40074067 |
| 56 | MP0000733_abnormal_muscle_development | 1.37460442 |
| 57 | MP0004185_abnormal_adipocyte_glucose | 1.36461823 |
| 58 | MP0004510_myositis | 1.36071099 |
| 59 | MP0002249_abnormal_larynx_morphology | 1.34305211 |
| 60 | MP0003633_abnormal_nervous_system | 1.31891387 |
| 61 | MP0000759_abnormal_skeletal_muscle | 1.28416585 |
| 62 | MP0000579_abnormal_nail_morphology | 1.25170613 |
| 63 | MP0008775_abnormal_heart_ventricle | 1.23065581 |
| 64 | MP0002557_abnormal_social/conspecific_i | 1.22220911 |
| 65 | * MP0002066_abnormal_motor_capabilities/c | 1.21672751 |
| 66 | MP0008961_abnormal_basal_metabolism | 1.18668030 |
| 67 | * MP0002184_abnormal_innervation | 1.17941322 |
| 68 | MP0004885_abnormal_endolymph | 1.17872454 |
| 69 | MP0003879_abnormal_hair_cell | 1.17545536 |
| 70 | * MP0005369_muscle_phenotype | 1.17452148 |
| 71 | MP0000013_abnormal_adipose_tissue | 1.15297384 |
| 72 | * MP0000955_abnormal_spinal_cord | 1.14221354 |
| 73 | MP0000537_abnormal_urethra_morphology | 1.12435832 |
| 74 | MP0001346_abnormal_lacrimal_gland | 1.11423970 |
| 75 | MP0005385_cardiovascular_system_phenoty | 1.06347114 |
| 76 | MP0001544_abnormal_cardiovascular_syste | 1.06347114 |
| 77 | MP0006138_congestive_heart_failure | 1.05702888 |
| 78 | MP0000750_abnormal_muscle_regeneration | 1.05097153 |
| 79 | * MP0002882_abnormal_neuron_morphology | 1.04850981 |
| 80 | MP0003631_nervous_system_phenotype | 1.03739985 |
| 81 | MP0005646_abnormal_pituitary_gland | 1.01915721 |
| 82 | MP0004142_abnormal_muscle_tone | 1.01876046 |
| 83 | MP0000778_abnormal_nervous_system | 1.00740947 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 1.00272924 |
| 85 | MP0003075_altered_response_to | 0.99897908 |
| 86 | MP0005409_darkened_coat_color | 0.99410130 |
| 87 | MP0005666_abnormal_adipose_tissue | 0.97981879 |
| 88 | MP0005076_abnormal_cell_differentiation | 0.97014793 |
| 89 | MP0000003_abnormal_adipose_tissue | 0.94906886 |
| 90 | MP0008874_decreased_physiological_sensi | 0.93111117 |
| 91 | MP0010630_abnormal_cardiac_muscle | 0.92036226 |
| 92 | MP0009672_abnormal_birth_weight | 0.90753312 |
| 93 | MP0005623_abnormal_meninges_morphology | 0.90572886 |
| 94 | MP0003690_abnormal_glial_cell | 0.89550721 |
| 95 | MP0001502_abnormal_circadian_rhythm | 0.89291888 |
| 96 | MP0000462_abnormal_digestive_system | 0.89071779 |
| 97 | MP0005375_adipose_tissue_phenotype | 0.88867809 |
| 98 | MP0005535_abnormal_body_temperature | 0.88325540 |
| 99 | MP0004043_abnormal_pH_regulation | 0.87424280 |
| 100 | MP0001984_abnormal_olfaction | 0.87192427 |
| 101 | MP0003283_abnormal_digestive_organ | 0.87094814 |
| 102 | MP0006276_abnormal_autonomic_nervous | 0.85254808 |
| 103 | MP0005670_abnormal_white_adipose | 0.79415134 |
| 104 | MP0002234_abnormal_pharynx_morphology | 0.77801614 |
| 105 | MP0002332_abnormal_exercise_endurance | 0.76102361 |
| 106 | MP0000534_abnormal_ureter_morphology | 0.75994313 |
| 107 | * MP0002229_neurodegeneration | 0.75981042 |
| 108 | * MP0002152_abnormal_brain_morphology | 0.73282075 |
| 109 | MP0008872_abnormal_physiological_respon | 0.72933806 |
| 110 | MP0002796_impaired_skin_barrier | 0.71050366 |
| 111 | MP0002127_abnormal_cardiovascular_syste | 0.70396872 |
| 112 | MP0002069_abnormal_eating/drinking_beha | 0.68666031 |
| 113 | * MP0000920_abnormal_myelination | 0.68165137 |
| 114 | MP0005645_abnormal_hypothalamus_physiol | 0.67039751 |
| 115 | MP0001905_abnormal_dopamine_level | 0.65656399 |
| 116 | MP0000604_amyloidosis | 0.65447143 |
| 117 | MP0003632_abnormal_nervous_system | 0.65236745 |
| 118 | MP0001529_abnormal_vocalization | 0.65041514 |
| 119 | MP0003787_abnormal_imprinting | 0.64283262 |
| 120 | MP0006036_abnormal_mitochondrial_physio | 0.63748534 |
| 121 | * MP0003634_abnormal_glial_cell | 0.63074738 |
| 122 | * MP0002108_abnormal_muscle_morphology | 0.61561233 |
| 123 | MP0002090_abnormal_vision | 0.61531054 |
| 124 | MP0003122_maternal_imprinting | 0.60592413 |
| 125 | MP0002089_abnormal_postnatal_growth/wei | 0.58832343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 6.01350648 |
| 2 | Myokymia (HP:0002411) | 5.69772073 |
| 3 | Focal motor seizures (HP:0011153) | 5.37241807 |
| 4 | Exercise-induced myalgia (HP:0003738) | 4.86370611 |
| 5 | Sudden death (HP:0001699) | 4.84555252 |
| 6 | Visual hallucinations (HP:0002367) | 4.54116422 |
| 7 | Bundle branch block (HP:0011710) | 4.39176906 |
| 8 | Ventricular fibrillation (HP:0001663) | 4.33791076 |
| 9 | Exercise-induced muscle cramps (HP:0003710) | 4.21096457 |
| 10 | Focal seizures (HP:0007359) | 4.20953812 |
| 11 | Distal lower limb muscle weakness (HP:0009053) | 4.10834977 |
| 12 | Myopathic facies (HP:0002058) | 4.01543271 |
| 13 | Calf muscle hypertrophy (HP:0008981) | 4.01537028 |
| 14 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.90859097 |
| 15 | Action tremor (HP:0002345) | 3.74997614 |
| 16 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.70247995 |
| 17 | Atrial fibrillation (HP:0005110) | 3.47769946 |
| 18 | Primary atrial arrhythmia (HP:0001692) | 3.35769517 |
| 19 | Myotonia (HP:0002486) | 3.34967799 |
| 20 | Prolonged QT interval (HP:0001657) | 3.31721753 |
| 21 | Distal arthrogryposis (HP:0005684) | 3.30782307 |
| 22 | Abnormality of the calf musculature (HP:0001430) | 3.28909848 |
| 23 | Hyporeflexia of lower limbs (HP:0002600) | 3.27617665 |
| 24 | Progressive cerebellar ataxia (HP:0002073) | 3.24848315 |
| 25 | Difficulty running (HP:0009046) | 3.21986883 |
| 26 | Syncope (HP:0001279) | 3.20110699 |
| 27 | Atonic seizures (HP:0010819) | 3.19674466 |
| 28 | Supraventricular tachycardia (HP:0004755) | 3.18886059 |
| 29 | Dysmetric saccades (HP:0000641) | 3.17009050 |
| 30 | Ankle clonus (HP:0011448) | 3.12235526 |
| 31 | Muscle fiber splitting (HP:0003555) | 3.10890263 |
| 32 | Supraventricular arrhythmia (HP:0005115) | 3.10318609 |
| 33 | Heart block (HP:0012722) | 3.06857824 |
| 34 | Round ear (HP:0100830) | 3.05438243 |
| 35 | Febrile seizures (HP:0002373) | 3.02361485 |
| 36 | Abnormal EKG (HP:0003115) | 3.01879245 |
| 37 | Depression (HP:0000716) | 3.00656371 |
| 38 | Myoglobinuria (HP:0002913) | 3.00328719 |
| 39 | Generalized tonic-clonic seizures (HP:0002069) | 3.00301984 |
| 40 | Poor eye contact (HP:0000817) | 2.99879594 |
| 41 | Distal lower limb amyotrophy (HP:0008944) | 2.96536698 |
| 42 | Absence seizures (HP:0002121) | 2.95068416 |
| 43 | EMG: myopathic abnormalities (HP:0003458) | 2.93538452 |
| 44 | Ventricular arrhythmia (HP:0004308) | 2.91795433 |
| 45 | Supranuclear gaze palsy (HP:0000605) | 2.91118126 |
| 46 | Epileptic encephalopathy (HP:0200134) | 2.90001574 |
| 47 | Dysdiadochokinesis (HP:0002075) | 2.88760500 |
| 48 | Neck muscle weakness (HP:0000467) | 2.87913013 |
| 49 | Ventricular tachycardia (HP:0004756) | 2.86983810 |
| 50 | Postural instability (HP:0002172) | 2.85534790 |
| 51 | Abnormal atrioventricular conduction (HP:0005150) | 2.83117599 |
| 52 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.82067625 |
| 53 | Subaortic stenosis (HP:0001682) | 2.80122016 |
| 54 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.80122016 |
| 55 | Impaired social interactions (HP:0000735) | 2.79971022 |
| 56 | Abnormal social behavior (HP:0012433) | 2.79971022 |
| 57 | Rhabdomyolysis (HP:0003201) | 2.78560921 |
| 58 | Ulnar deviation of the wrist (HP:0003049) | 2.77533227 |
| 59 | Anxiety (HP:0000739) | 2.74072700 |
| 60 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.73370331 |
| 61 | Broad-based gait (HP:0002136) | 2.70777718 |
| 62 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.67576097 |
| 63 | Obstructive sleep apnea (HP:0002870) | 2.66695803 |
| 64 | Pheochromocytoma (HP:0002666) | 2.66272586 |
| 65 | Dialeptic seizures (HP:0011146) | 2.62302367 |
| 66 | Dysmetria (HP:0001310) | 2.62099034 |
| 67 | Atrioventricular block (HP:0001678) | 2.61495180 |
| 68 | Urinary urgency (HP:0000012) | 2.61367510 |
| 69 | Gaze-evoked nystagmus (HP:0000640) | 2.60921317 |
| 70 | Bulbar palsy (HP:0001283) | 2.57547177 |
| 71 | Abnormality of the lower motor neuron (HP:0002366) | 2.53810308 |
| 72 | Areflexia of lower limbs (HP:0002522) | 2.48661634 |
| 73 | Frequent falls (HP:0002359) | 2.45865554 |
| 74 | Hyperacusis (HP:0010780) | 2.43496580 |
| 75 | Increased variability in muscle fiber diameter (HP:0003557) | 2.39506889 |
| 76 | Hemiplegia (HP:0002301) | 2.38851323 |
| 77 | Lower limb amyotrophy (HP:0007210) | 2.35703161 |
| 78 | Muscle stiffness (HP:0003552) | 2.33602376 |
| 79 | Progressive muscle weakness (HP:0003323) | 2.31666223 |
| 80 | Asymmetric septal hypertrophy (HP:0001670) | 2.28520112 |
| 81 | Truncal ataxia (HP:0002078) | 2.27330001 |
| 82 | Neuroendocrine neoplasm (HP:0100634) | 2.25532603 |
| 83 | Rapidly progressive (HP:0003678) | 2.25259446 |
| 84 | Genetic anticipation (HP:0003743) | 2.24422764 |
| 85 | Papilledema (HP:0001085) | 2.23463870 |
| 86 | Intention tremor (HP:0002080) | 2.23089910 |
| 87 | Fetal akinesia sequence (HP:0001989) | 2.21529907 |
| 88 | Annular pancreas (HP:0001734) | 2.18899685 |
| 89 | Rimmed vacuoles (HP:0003805) | 2.17781332 |
| 90 | Calcaneovalgus deformity (HP:0001848) | 2.17406425 |
| 91 | Muscle fiber inclusion bodies (HP:0100299) | 2.17318143 |
| 92 | Ragged-red muscle fibers (HP:0003200) | 2.14383615 |
| 93 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.13855466 |
| 94 | Difficulty climbing stairs (HP:0003551) | 2.13107795 |
| 95 | Mutism (HP:0002300) | 2.12500713 |
| 96 | Torticollis (HP:0000473) | 2.07493281 |
| 97 | Abnormal eating behavior (HP:0100738) | 2.06659294 |
| 98 | Dilated cardiomyopathy (HP:0001644) | 2.06400586 |
| 99 | Palpitations (HP:0001962) | 2.05426139 |
| 100 | Lipoatrophy (HP:0100578) | 2.04905826 |
| 101 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.04738257 |
| 102 | Impaired smooth pursuit (HP:0007772) | 2.02365901 |
| 103 | Scanning speech (HP:0002168) | 2.02143175 |
| 104 | Resting tremor (HP:0002322) | 2.01813656 |
| 105 | Akinesia (HP:0002304) | 1.99568214 |
| 106 | Hypercortisolism (HP:0001578) | 1.99116176 |
| 107 | Spastic gait (HP:0002064) | 1.98598015 |
| 108 | Tetraplegia (HP:0002445) | 1.98337038 |
| 109 | Increased connective tissue (HP:0009025) | 1.97671195 |
| 110 | Bradykinesia (HP:0002067) | 1.96632068 |
| 111 | EMG: neuropathic changes (HP:0003445) | 1.96459887 |
| 112 | Type 1 muscle fiber predominance (HP:0003803) | 1.95491269 |
| 113 | Cerebral inclusion bodies (HP:0100314) | 1.95093204 |
| 114 | Scapular winging (HP:0003691) | 1.95031030 |
| 115 | Right ventricular cardiomyopathy (HP:0011663) | 1.94608971 |
| 116 | Lower limb muscle weakness (HP:0007340) | 1.94259575 |
| 117 | Left ventricular hypertrophy (HP:0001712) | 1.93726836 |
| 118 | Testicular atrophy (HP:0000029) | 1.92939913 |
| 119 | Insomnia (HP:0100785) | 1.92923424 |
| 120 | Progressive inability to walk (HP:0002505) | 1.92214650 |
| 121 | Central scotoma (HP:0000603) | 1.91334149 |
| 122 | Foot dorsiflexor weakness (HP:0009027) | 1.91288059 |
| 123 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.91190719 |
| 124 | Abnormality of the foot musculature (HP:0001436) | 1.88241836 |
| 125 | Focal dystonia (HP:0004373) | 1.87900544 |
| 126 | Amblyopia (HP:0000646) | 1.86862702 |
| 127 | Impaired vibratory sensation (HP:0002495) | 1.86671627 |
| 128 | Termporal pattern (HP:0011008) | 1.86539825 |
| 129 | Absent phalangeal crease (HP:0006109) | 1.81833432 |
| 130 | Deformed tarsal bones (HP:0008119) | 1.80731693 |
| 131 | Achilles tendon contracture (HP:0001771) | 1.79229834 |
| 132 | Generalized muscle weakness (HP:0003324) | 1.74978839 |
| 133 | J-shaped sella turcica (HP:0002680) | 1.73092454 |
| 134 | Upper limb amyotrophy (HP:0009129) | 1.71135123 |
| 135 | Distal upper limb amyotrophy (HP:0007149) | 1.71135123 |
| 136 | Slow progression (HP:0003677) | 1.70457740 |
| 137 | Hyperthyroidism (HP:0000836) | 1.70411576 |
| 138 | Malignant hyperthermia (HP:0002047) | 1.68046428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.45497919 |
| 2 | NTRK3 | 3.43956579 |
| 3 | EPHA4 | 3.38506192 |
| 4 | PHKG2 | 2.84983853 |
| 5 | PHKG1 | 2.84983853 |
| 6 | PRKD3 | 2.51951418 |
| 7 | MAP3K4 | 2.44334856 |
| 8 | LMTK2 | 2.43485732 |
| 9 | PAK6 | 2.39831943 |
| 10 | EEF2K | 2.37021396 |
| 11 | DAPK2 | 2.32338124 |
| 12 | SIK1 | 2.31120535 |
| 13 | MINK1 | 2.28663674 |
| 14 | KSR2 | 2.19783170 |
| 15 | CAMKK1 | 2.06570663 |
| 16 | PINK1 | 2.03397164 |
| 17 | MARK1 | 1.99754476 |
| 18 | TTN | 1.93833368 |
| 19 | STK38 | 1.89662295 |
| 20 | SCYL2 | 1.88212505 |
| 21 | SMG1 | 1.85794173 |
| 22 | MAP2K4 | 1.81955781 |
| 23 | MAPKAPK3 | 1.79682719 |
| 24 | EPHA2 | 1.75697887 |
| 25 | NEK1 | 1.74254540 |
| 26 | OBSCN | 1.65158024 |
| 27 | NTRK1 | 1.63494689 |
| 28 | NTRK2 | 1.60061965 |
| 29 | MAP2K7 | 1.59157126 |
| 30 | RPS6KB2 | 1.53887568 |
| 31 | DMPK | 1.49664206 |
| 32 | RIPK1 | 1.41575619 |
| 33 | TRIB3 | 1.34464816 |
| 34 | TAOK1 | 1.33100460 |
| 35 | CDK5 | 1.31973699 |
| 36 | PDK4 | 1.27926255 |
| 37 | PDK3 | 1.27926255 |
| 38 | LIMK1 | 1.22846851 |
| 39 | TESK1 | 1.20175563 |
| 40 | NEK6 | 1.20165567 |
| 41 | RIPK4 | 1.16913301 |
| 42 | GRK5 | 1.14652495 |
| 43 | CAMK1 | 1.11456357 |
| 44 | TYRO3 | 1.11036125 |
| 45 | PRKCH | 1.10929025 |
| 46 | CAMKK2 | 1.10797644 |
| 47 | KSR1 | 1.08019698 |
| 48 | PAK3 | 1.07060023 |
| 49 | UHMK1 | 1.06543669 |
| 50 | MAP3K7 | 1.03646230 |
| 51 | LATS2 | 1.03206636 |
| 52 | IRAK3 | 1.01821549 |
| 53 | MAP3K12 | 0.98502223 |
| 54 | ALK | 0.98364460 |
| 55 | WNK1 | 0.97841912 |
| 56 | DAPK1 | 0.97438046 |
| 57 | MAP3K2 | 0.97125860 |
| 58 | STK11 | 0.97066788 |
| 59 | PKN2 | 0.95903336 |
| 60 | RET | 0.95897728 |
| 61 | MAP2K2 | 0.94186898 |
| 62 | CDK19 | 0.93609463 |
| 63 | ARAF | 0.93322854 |
| 64 | MUSK | 0.92814003 |
| 65 | PRKCG | 0.92088491 |
| 66 | PRPF4B | 0.89231337 |
| 67 | CAMK2A | 0.86170532 |
| 68 | SIK2 | 0.84583584 |
| 69 | PDK1 | 0.84237938 |
| 70 | SGK3 | 0.84172689 |
| 71 | CDC42BPA | 0.84070411 |
| 72 | CAMK1D | 0.82856322 |
| 73 | MAP3K13 | 0.82310749 |
| 74 | FES | 0.81853391 |
| 75 | SGK223 | 0.81764404 |
| 76 | SGK494 | 0.81764404 |
| 77 | PDPK1 | 0.80898595 |
| 78 | MAP2K1 | 0.78220814 |
| 79 | BRAF | 0.78192374 |
| 80 | CAMK2D | 0.75964389 |
| 81 | CAMK4 | 0.74919112 |
| 82 | PLK2 | 0.74803940 |
| 83 | NME2 | 0.74155815 |
| 84 | MAP3K1 | 0.73731833 |
| 85 | MTOR | 0.71365095 |
| 86 | BRSK1 | 0.68612676 |
| 87 | AKT2 | 0.68179315 |
| 88 | TNIK | 0.68097449 |
| 89 | SGK1 | 0.65601892 |
| 90 | SGK2 | 0.65075142 |
| 91 | CDK15 | 0.64291267 |
| 92 | PRKD1 | 0.63701594 |
| 93 | PTK2B | 0.63267506 |
| 94 | MAPK12 | 0.63167853 |
| 95 | MAP3K11 | 0.62797436 |
| 96 | CDK18 | 0.62114360 |
| 97 | MAPK13 | 0.62077402 |
| 98 | IRAK2 | 0.61539893 |
| 99 | PDK2 | 0.61462613 |
| 100 | DAPK3 | 0.60767845 |
| 101 | PRKCI | 0.60280650 |
| 102 | CAMK2G | 0.59828735 |
| 103 | PRKD2 | 0.58979827 |
| 104 | CDK14 | 0.57506931 |
| 105 | MARK2 | 0.56996211 |
| 106 | RPS6KA2 | 0.55733195 |
| 107 | ROCK1 | 0.55663829 |
| 108 | RPS6KA3 | 0.55588079 |
| 109 | RAF1 | 0.54657379 |
| 110 | CDK11A | 0.54393352 |
| 111 | NME1 | 0.53532279 |
| 112 | PDGFRA | 0.51033092 |
| 113 | CAMK2B | 0.50406380 |
| 114 | MYLK | 0.50232443 |
| 115 | PNCK | 0.50232063 |
| 116 | PTK2 | 0.50159394 |
| 117 | ROCK2 | 0.47810521 |
| 118 | PRKAA1 | 0.47265989 |
| 119 | TNK2 | 0.46574793 |
| 120 | CAMK1G | 0.45752143 |
| 121 | PIK3CA | 0.44293791 |
| 122 | TAOK2 | 0.40838654 |
| 123 | RPS6KB1 | 0.40410371 |
| 124 | PTK6 | 0.39808959 |
| 125 | MAPK10 | 0.38990185 |
| 126 | ILK | 0.38500712 |
| 127 | MAP2K6 | 0.38440600 |
| 128 | FER | 0.37549528 |
| 129 | ICK | 0.37389578 |
| 130 | CCNB1 | 0.36013320 |
| 131 | TESK2 | 0.35355993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.67396338 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.65155741 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.51680212 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.40373055 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.28055335 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.27209286 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.21666973 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.17112682 |
| 9 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.17083425 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.15398596 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.12185766 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.03961704 |
| 13 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.97472505 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.94976925 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.94826161 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.92646084 |
| 17 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.91160897 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.85744865 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.78440752 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.75339580 |
| 21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.74319968 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.73202033 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.70966261 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.63570552 |
| 25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.61433803 |
| 26 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.50573830 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.50244444 |
| 28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.43472110 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.42196695 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.40055555 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.39843763 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.39793638 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.38966093 |
| 34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.36182307 |
| 35 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.35198166 |
| 36 | Long-term depression_Homo sapiens_hsa04730 | 1.33995696 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.33188018 |
| 38 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26525482 |
| 39 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.23843459 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.23485302 |
| 41 | Cocaine addiction_Homo sapiens_hsa05030 | 1.20372212 |
| 42 | Gap junction_Homo sapiens_hsa04540 | 1.20358249 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17159956 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.16743445 |
| 45 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.15385868 |
| 46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.08558729 |
| 47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08216622 |
| 48 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.08136741 |
| 49 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05051381 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.00587733 |
| 51 | Glioma_Homo sapiens_hsa05214 | 0.98439600 |
| 52 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.91771936 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88335856 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87002340 |
| 55 | Melanogenesis_Homo sapiens_hsa04916 | 0.84666537 |
| 56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82275904 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82210678 |
| 58 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.78602577 |
| 59 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77644188 |
| 60 | Prion diseases_Homo sapiens_hsa05020 | 0.77511762 |
| 61 | Thyroid cancer_Homo sapiens_hsa05216 | 0.75220024 |
| 62 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73151208 |
| 63 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.72711529 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71644038 |
| 65 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.70579594 |
| 66 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.70228569 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69528488 |
| 68 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.69221397 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68853863 |
| 70 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68540761 |
| 71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67374756 |
| 72 | Bile secretion_Homo sapiens_hsa04976 | 0.66896687 |
| 73 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66124725 |
| 74 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.65716311 |
| 75 | Axon guidance_Homo sapiens_hsa04360 | 0.65607258 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65482416 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64630758 |
| 78 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.64618466 |
| 79 | Alzheimers disease_Homo sapiens_hsa05010 | 0.62863525 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61499537 |
| 81 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58538625 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57197449 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55497918 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55224607 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54774283 |
| 86 | Parkinsons disease_Homo sapiens_hsa05012 | 0.52794705 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52537892 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52313080 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.49534585 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49010744 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.48391741 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47476439 |
| 93 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.46850675 |
| 94 | Carbon metabolism_Homo sapiens_hsa01200 | 0.46531944 |
| 95 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.46132044 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44724289 |
| 97 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.43278414 |
| 98 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.41466867 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41015635 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40607533 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39785742 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39535821 |
| 103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.39506117 |
| 104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39198693 |
| 105 | Tight junction_Homo sapiens_hsa04530 | 0.38739319 |
| 106 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37592711 |
| 107 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.35679218 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35394785 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35188504 |
| 110 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.34503027 |
| 111 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33925335 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32337313 |
| 113 | Platelet activation_Homo sapiens_hsa04611 | 0.32189338 |
| 114 | Focal adhesion_Homo sapiens_hsa04510 | 0.32160968 |
| 115 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.31224857 |

